BRIEF-Fibrocell receives orphan drug designation for FCX-013
April 25, 2016 at 08:26 AM EDT
* Sats receives orphan drug designation from the FDA for for FCX-013 for the treatment of localized scleroderma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.